(Q46914015)

26 December 2017

title

Vaccination coverage against measles in German-born and foreign-born children and identification of unvaccinated subgroups in Germany (English)

1 reference

26 December 2017

0 references

1 reference

Christina Poethko-Müller

1

1 reference

26 December 2017

Ute Ellert

2

1 reference

26 December 2017

Ronny Kuhnert

3

1 reference

26 December 2017

Hannelore Neuhauser

4

1 reference

26 December 2017

Martin Schlaud

5

1 reference

26 December 2017

Liane Schenk

6

1 reference

26 December 2017

language of work or name

English

0 references

publication date

12 February 2009

1 reference

26 December 2017

published in

Vaccine

1 reference

26 December 2017

volume

27

1 reference

26 December 2017

issue

19

1 reference

26 December 2017

page(s)

2563-2569

1 reference

26 December 2017

[Vaccination coverage and predictors for vaccination level. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Progress toward measles elimination in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Large measles outbreak at a German public school, 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Epidemiology of measles in the United States, 1997-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

International importation of measles virus--United States, 1993-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Measles elimination in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Suboptimal measles-mumps-rubella vaccination coverage facilitates an imported measles outbreak in ireland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Summary and conclusions: measles elimination meeting, 16-17 March 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Comparisons of immunisation accessibility between non-US born and US-born children in New York City.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

The impact of sociodemographic variables on immunization coverage of children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Racial/ethnic disparities in preschool immunizations: United States, 1996-2001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Vaccination rates in a multicultural population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Seroprevalence of Measles, Rubella, and Varicella in Refugees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Vaccination coverage of foreign-born children 19 to 35 months of age: findings from the National Immunization Survey, 1999-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

[Children and adolescents in Germany with a migration background. Methodical aspects in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

The theory of measles elimination: implications for the design of elimination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

The effect of heterogeneity in measles vaccination on population immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Lack of immunization documentation in Minnesota refugees: challenges for refugee preventive health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Immunisation status of children in Germany: temporal trends and regional differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Sustained measles elimination in Australia and priorities for long term maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Factors influencing vaccine uptake in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Differences in risk factors for partial and no immunisation in the first year of life: prospective cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Children who have received no vaccines: who are they and where do they live?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

[The vaccination coverage among children aged 24 - 30 months in pediatric offices November 1999 - May 2001. The influence of socio-demographic characteristics]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Risk factors for undervaccination against measles in a large sample of preschool children from rural Bavaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

Impact of anti-vaccine movements on pertussis control: the untold story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.009

10.1016/J.VACCINE.2009.02.009

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

19428862

1 reference

26 December 2017